ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01139593
Recruitment Status : Completed
First Posted : June 8, 2010
Last Update Posted : December 9, 2015
Sponsor:
Information provided by (Responsible Party):
Fady I. Sharara, M.D, Virginia Center for Reproductive Medicine

Brief Summary:
This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Condition or disease
Infertility

Study Type : Observational
Actual Enrollment : 128 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies
Study Start Date : June 2010
Actual Primary Completion Date : November 2015
Actual Study Completion Date : December 2015

Group/Cohort
morning dose
women undergoing IVF/ICSi taking their gonadotropin dose in the am
evening dose
Women undergoing IVF/ICSI taking their gonadotropin in the evening



Primary Outcome Measures :
  1. Live birth rate [ Time Frame: 4 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 42 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Infertile women between 21 and 44 years old
Criteria

Inclusion Criteria:

  • women between 21-42 undergoing IVF

Exclusion Criteria:

  • women > 45,
  • women with one ovary,
  • donor egg,
  • surrogacy,
  • FET cycles,
  • uterine problems,
  • large fibroids

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01139593


Locations
United States, Virginia
Virginia Center for Reproductive Medicine
Reston, Virginia, United States, 20190
Sponsors and Collaborators
Virginia Center for Reproductive Medicine

Responsible Party: Fady I. Sharara, M.D, Medical Director, Virginia Center for Reproductive Medicine
ClinicalTrials.gov Identifier: NCT01139593     History of Changes
Other Study ID Numbers: VCRM 5
First Posted: June 8, 2010    Key Record Dates
Last Update Posted: December 9, 2015
Last Verified: December 2015

Keywords provided by Fady I. Sharara, M.D, Virginia Center for Reproductive Medicine:
IVF
ICSI
gonadotropin
am dose
pm dose
pregnancy
implantation
live birth

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female